Nicholas Clapper, DO
Vascular Surgery · Jackson, MSNPI 1942611314
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,653 of the $7,239 with a category attached, or 64.3%. 21 manufacturers reported payments, led by Endologix LLC at 30.8% of the total. 2025 is the largest year on record at $2,669, 4.6 times the $576 reported in 2021. That places this record below the midpoint for vascular surgery clinicians in MS, where the typical reported total is $7,056.
Across 80 payments — averaging $90.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$2K
- W. L. Gore & Associates, Inc.$2K
- Angiodynamics, Inc.$2K
- Organogenesis Inc.$408
- Silk Road Medical, Inc.$292
- Bard Peripheral Vascular, Inc.$219
- plus $733 from 15 others
What the payments were for
- Travel & lodging$1,05815%
- Food & beverage$4,65364%
- Other$1,52821%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 7 | $2,227 |
| W. L. Gore & Associates, Inc. | 15 | $1,833 |
| Angiodynamics, Inc. | 1 | $1,528 |
| Organogenesis Inc. | 22 | $408 |
| Silk Road Medical, Inc. | 2 | $292 |
| Bard Peripheral Vascular, Inc. | 4 | $219 |
| Philips North America LLC | 2 | $183 |
| Boston Scientific | 4 | $112 |
| Stryker | 3 | $95 |
| Lemaitre Vascular, Inc. | 5 | $64 |
| Kerecis Limited | 2 | $55 |
| Medtronic | 3 | $43 |
| Reflow Medical Inc | 2 | $42 |
| Cagent Vascular Inc | 1 | $29 |
| Penumbra, Inc. | 1 | $24 |
| Cardiva Medical, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $17 |
| Argon Medical Devices, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Vifor Pharma, Inc. | 1 | $13 |
| Medela LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$1,926
- Auryon Laser System 100-120 Vac$1,528
- GORE TAG Thoracic Endoprosthesis$782
- GORE TAG Thoracic Branch Endoprosthesis$444
- ENDOCROSS Device$301
- Torus Stent Graft System$301
- ENROUTE Transcarotid Neuroprotection System$292
- ENROUTE Transcarotid Stent$292
- RotarexS 6 F x 135 cm$167
- ENROUTE .014 Guidewire$124
- ENHANCE Transcarotid Peripheral Access Kit$124
- GORE TAG Conformable Thoracic Endoprosthesis$109
- GORE VIABAHN Endoprosthesis$104
- PuraPly$103
- (4067) Tack Endo Sys BTK$101
How this compares
$7,239 in reported general payments places this provider in the 50th percentile of 39 vascular surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $24,329 |
| XareltoRivaroxaban | 18 | $13,533 |
| ClopidogrelClopidogrel Bisulfate | 115 | $1,435 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 68 | $423 |
| Cilostazol | 22 | $289 |
| Prednisone | 15 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $14 | $13,53318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 39 vascular surgery providers in Mississippi.
Other vascular surgery in Jackson
- Seshadri RajuJackson$573K
- Zachary BaldwinJackson$25K
- Jennifer DinningJackson$18K
- Ian BrastauskasJackson$10K
- John ShaughnessyJackson$10K
- Marc MitchellJackson$7K
- Miguel VillalobosJackson$7K
- Joshua PlantJackson$7K
- Mrinal ShuklaJackson$7K
- Taimur SaleemJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.